Buyers of medical practices fall into two groups, and each uses its own earnings figure. Private equity platforms, health systems and their management services organizations (MSOs) price on adjusted EBITDA. They pay each physician a market wage for clinical work, subtract it, and apply the multiple to what remains. Individual physicians and small groups buying a single practice usually price on seller's discretionary earnings (SDE), which adds the owner's full pay and perks back into profit.
Because SDE keeps the owner's pay inside the earnings, an SDE multiple comes out lower than an EBITDA multiple for the same practice at the same price. Revenue multiples appear too, mostly as a cross-check on primary care. The guide to how buyers value a small business covers the adjustments buyers make.
What the published medical multiples show
Nine figures from three publishers are on file. The AMA and MGMA publish no sale multiples.
- FOCUS Investment Banking (24 Apr 2026) says its ranges reflect consensus 2024 and 2025 deal data compiled by Levin Associates and PitchBook, for private equity buyers. Add-on acquisitions by existing platforms run 6x to 9x EBITDA. Platform investments run 10x to 15x. Groups with more than $5M of EBITDA run 11x to 13x. By specialty, primary care add-ons run 3x to 6x, against 8x to 12x for primary care platforms and 8x to 12x for cardiology add-ons.
- Sofer Advisors (updated 11 Nov 2026) puts practices with $500,000 to $1M of EBITDA at 6x to 8x and practices with $5M or more at 10x to 12x. For primary care it gives 0.5x to 0.7x revenue and 3x to 5x EBITDA.
- BizBuySell recorded 139 medical practice sales in 2025 at an average 2.58x SDE and 0.70x revenue, with a median sale price of $537,000. Its benchmark page covering 2021 to 2025 says half of practices sold between 1.46x and 2.94x SDE.
Published multiples for medical practices
Low to high, by metric and size band as each source publishes them
Why the medical ranges differ
Buyer and earnings measure. The BizBuySell figures describe small independent practices sold mostly to physicians, on SDE. The FOCUS and Sofer figures describe deals with private equity backed buyers, on EBITDA. The two sets measure different businesses with different earnings figures.
Platform against add-on. FOCUS separates the first practice a sponsor buys in a specialty from the practices bolted on later. A platform carries management, systems and room to grow, and FOCUS shows it four or more turns above an add-on of similar specialty.
Specialty. Primary care sits at the bottom of every published table. Sofer's 3x to 5x EBITDA for primary care and FOCUS's 3x to 6x for primary care add-ons broadly agree. Specialty add-ons on the FOCUS page run higher: orthopedics 6x to 9x, gastroenterology 7x to 9x, ophthalmology 7x to 11x.
Consensus ranges against medians. FOCUS publishes compiled consensus ranges drawn from Levin Associates and PitchBook deal lists, and those lists are not public, so the ranges cannot be checked as medians. Sofer Advisors publishes valuation-firm guidance with no deal count. BizBuySell's 139 sales are a real deal count, voluntarily reported by brokers, and its 2021 to 2025 middle-half range shows how wide the spread is even among small practices.
What moves a medical practice multiple
| Factor | Why buyers care |
|---|---|
| Specialty and ancillaries | FOCUS says surgery centers, imaging and labs add roughly two to four turns. Those services add revenue beyond physician visits. |
| Payer mix | FOCUS says more commercial and self-pay revenue moves the multiple by about 1.5 to 2 turns. The mix sets the rates behind every visit a buyer is pricing. |
| Size | Platform-scale groups trade several turns above add-on practices, per FOCUS. |
| Physician dependence | A buyer pays for earnings that continue after closing. Revenue tied to one physician is only as durable as that physician's commitment. |
| Ownership structure | Many states have corporate practice of medicine laws. The Milbank Memorial Fund explains that investors usually own an MSO that contracts with a physician-owned practice, which shapes what a buyer can acquire. |
The medical practice buyers page lists platforms and the criteria they publish.
A worked example on a published range
At the 6x to 9x EBITDA range FOCUS Investment Banking publishes for add-on acquisitions by private equity backed platforms, $1M of adjusted EBITDA implies $6M to $9M. At BizBuySell's middle-half range of 1.46x to 2.94x SDE, $350,000 of SDE implies about $511,000 to $1.03M. Both lines are arithmetic on published figures, shown as an illustration. Neither values any practice.
Headline price and value received
A price stated as a multiple is the total of several payments that arrive at different times and carry different risks. In the IBBA's Q2 2026 survey, sellers in deals of $5M to $50M received 83% of value in cash at close on average, with 6% in seller financing, 7% in earnouts and 4% in retained equity. Private equity deals often add rollover equity in the platform. William Blair, an investment bank, estimates 20% to 30% as the typical rollover in middle-market transactions.
Rolled equity usually pays out when the platform itself is sold, and earnouts are paid only if targets are met. The guide to earnouts and seller notes covers both, and the quality of earnings guide covers the review that sets the EBITDA the multiple applies to. With an offer in hand, the offer check shows its implied multiple and cash share, and the guide to judging an offer lists the terms to read first.
To apply these published ranges to your own earnings figure, open the private range tool for medical practices.
Turn these multiples into a price range. Open the private range tool. It runs in your browser and stores nothing you type.
Every published multiple across industries is on the valuation multiples page.
Questions owners ask
How is a medical practice valued?
Private equity platforms and management services organizations price on adjusted EBITDA after paying physicians a market wage. Small practices sold to individual physicians are usually priced on SDE, and BizBuySell's 2025 tables show an average 2.58x across 139 reported sales.
What multiples do physician practice acquisitions carry?
FOCUS Investment Banking, citing 2024 and 2025 deal data compiled by Levin Associates and PitchBook, puts add-on acquisitions at 6x to 9x EBITDA and platform investments at 10x to 15x.
Why do primary care practices trade lower than specialty practices?
FOCUS puts primary care add-ons at 3x to 6x EBITDA and cardiology add-ons at 8x to 12x. It says ancillary services such as surgery centers, imaging and labs add roughly two to four turns.
How long does it take to sell a medical practice?
BizBuySell's 2025 tables show a median of 191 days on market for reported medical practice sales. The IBBA's Q2 2026 survey puts engagement to close at 6 to 12 months across industries.
- FOCUS Investment Banking, Physician Practice M&A Multiples 2026, 2026-04-24. https://focusib.com/insights/article/physician-practice-ma-multiples-2026/
- Sofer Advisors, Medical Practice Valuation Multiples Guide 2025-2026, 2026-11-11. https://soferadvisors.com/insights/blog/medical-practice-valuation-multiples-2025-2026-complete-guide/
- BizBuySell Insight Report data tables, full-year 2025 by sector, undated page; FY2025 data (read 2026-11-18). https://www.bizbuysell.com/insight-report-data-tables/
- BizBuySell, Medical Practice valuation benchmarks, 2026. https://www.bizbuysell.com/learning-center/valuation-benchmarks/medical-practice/
- IBBA and M&A Source, Market Pulse Q2 2026 Executive Summary, 2026-08. https://www.ibba.org/wp-content/uploads/2026/08/mp-executive-courtesy-q2-2026.pdf
- William Blair, Rollover Equity: Wealth Planning Considerations, 2025. https://cd.www.williamblair.com/-/media/downloads/pwm/2025/williamblair_rollover-equity-wealth-planning-considerations.pdf
- Milbank Memorial Fund, The Corporate Backdoor to Medicine: How MSOs Are Reshaping Physician Practices, 2025-04-28. https://www.milbank.org/publications/the-corporate-backdoor-to-medicine-how-msos-are-reshaping-physician-practices/